+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doribax"

Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel

  • Report
  • February 2022
  • 180 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Doribax (doripenem) is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of antibiotics called carbapenems, which are used to treat serious infections caused by a wide range of bacteria. Doribax is used to treat complicated intra-abdominal infections, complicated urinary tract infections, and hospital-acquired pneumonia. It is also used to treat infections caused by certain bacteria that are resistant to other antibiotics. Doribax is available in both intravenous and oral formulations. Doribax is marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Other companies that market Doribax include AstraZeneca, Merck, and Pfizer. Show Less Read more